Dr. William Gunn is the Head of Academic Outreach for Mendeley, the leading research management tool for collaboration and discovery. Dr. Gunn attended Tulane University as a Louisiana Board of Regents Fellow, receiving his Ph.D in Biomedical Science from the Center for Gene Therapy at Tulane University in 2008. His research involved dissecting the molecular mechanism of bone metastasis in multiple myeloma and resulted in a novel treatment approach employing mesenchymal stem cells, the body's own reparative forces. Frustrated with the inefficiencies of the modern research process, he left academia and established the biology program at Genalyte, a novel diagnostics startup. From there, Dr. Gunn moved to Mendeley to pursue his mission of bringing modern network efficiencies to academic research.

His work at Genalyte, a molecular diagnostics startup, involved developing protein, DNA, and small molecule assays on their novel high-throughput assay platform.
He received his PhD from Tulane University, where he studied under Dr. Darwin Prockop at the Tulane Center for Gene Therapy. His dissertation is entitled "Investigating the Role of Human Multipotent Mesenchymal Stromal Cells in the Repair of Bone", in which he developed a model of multiple myeloma in mice and used it to test small molecule inhibitors of the interaction between multiple myeloma and bone precursor cells, promoting bone regeneration and repair of osteolytic lesions.